NCT02603497View on ClinicalTrials.gov

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 24, 2015

Primary Completion Date

December 19, 2016

Study Completion Date

December 19, 2016

Conditions
Patients With Impaired Renal Function
Interventions
DRUG

ASP015K

oral

Trial Locations (2)

Unknown

Site JP00001, Tokyo

Site JP00002, Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY